Link Pharma Chem Ltd
NSE: BSE: 524748
₹24.86
(5.79%)
Wed, 25 Mar 2026, 09:26 pm
Market Cap110.39M
PE Ratio81.48
Dividend0
Process Industries
Chemicals: Specialty
24.5KLink Pharma Chem Analysis
dividend
- Unable to evaluate Link Pharma Chem's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Link Pharma Chem's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Link Pharma Chem is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Link Pharma Chem is profitable, therefore cash runway is not a concern.
- Link Pharma Chem is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (107.7%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 4x debt.
- Link Pharma Chem's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (94.5% vs 16.4% today).
- Link Pharma Chem's level of debt (16.4%) compared to net worth is satisfactory (less than 40%).
- Interest payments on debt are not well covered by earnings (EBIT is 1.9x annual interest expense, ideally 3x coverage).
- High level of physical assets or inventory.
management
- The tenure for the Link Pharma Chem board of directors is about average.
- Satish's remuneration is about average for companies of similar size in India.
- Satish's compensation has been consistent with company performance over the past year, both up more than 20%.
- The tenure for the Link Pharma Chem management team is about average.
misc
- Link Pharma Chem is not covered by any analysts.
- Link Pharma Chem has significant price volatility in the past 3 months.
past
- Link Pharma Chem has delivered over 20% year on year earnings growth in the past 5 years.
- Link Pharma Chem's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Link Pharma Chem used its assets less efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Link Pharma Chem's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Link Pharma Chem has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Link Pharma Chem's 1-year earnings growth is negative, it can't be compared to the IN Chemicals industry average.
value
- Link Pharma Chem's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Link Pharma Chem's share price is below the future cash flow value, and at a substantial discount (> 40%).
- Link Pharma Chem is good value based on assets compared to the IN Chemicals industry average.
- 524748 outperformed the Market in India which returned -14.5% over the past year.
- Link Pharma Chem is overvalued based on earnings compared to the IN Chemicals industry average.
- Link Pharma Chem is overvalued based on earnings compared to the India market.
- 524748 underperformed the Chemicals industry which returned 2.2% over the past year.
- BSE:524748 is down -17.6% underperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:524748 is down -17.6% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800